Jeddah Health Cluster Two signs a cooperation agreement with Jamjoom Pharma to enhance healthcare
Jeddah Health Cluster Two has signed a strategic cooperation agreement with Jamjoom Pharma, one of the most prominent Saudi companies specializing in the pharmaceutical industry. This partnership aims to develop health services and raise the level of medical awareness in the Kingdom of Saudi Arabia.
This agreement comes within the framework of Jeddah Health Cluster Two's efforts to improve the quality of care provided to patients. Through this collaboration, the company will work to support training programs and develop the capabilities of medical staff working in the health facilities affiliated with the cluster.
The partnership also focuses on enhancing health awareness among community members by launching joint awareness initiatives. These initiatives aim to disseminate knowledge about the optimal use of medicines and the importance of disease prevention, which contributes to promoting public health in the region.
This step is part of the Kingdom's Vision 2030, which aims to develop the health sector and provide the best services to citizens and residents. It is expected that this agreement will contribute to the exchange of expertise between the public and private sectors to support innovation in the field of healthcare.
In conclusion, this partnership reflects the commitment of national institutions to work together to achieve excellence in medical services. Both parties are expected to begin implementing the terms of the agreement in the coming period to achieve tangible results that will benefit the community.